David Southwell – Biographie

David était President and Chief Executive Officer chez Inotek Pharmaceuticals, et Director chez Rocket Pharmaceuticals. David Southwell a rejoint PTC Therapeutics en 2025.

David Southwell est actuellement

• Chief Executive Officer at Volastra Therapeutics - View - Volastra Therapeutics org chart

• Senior Director of Engineering and Head of Site Reliability Engineering at Pex - View - Pex org chart

• Board Member at Sensorium Therapeutics - View - Sensorium Therapeutics org chart

• Chairman of the Board at Revolo Biotherapeutics - View - Revolo Biotherapeutics org chart

• Director at Rocket Pharmaceuticals - View - Rocket Pharmaceuticals org chart

• Member of the Board at PTC Therapeutics - View - PTC Therapeutics org chart

Créer une alerte
pour suivre le parcours de David Southwell.

David Southwell a obtenu un Bachelor of Arts in Economics de Rice University et un Master of Business Administration de Dartmouth College - The Tuck School of Business.

Ils ont aussi étudié à Rice University:

• James Turley - Citigroup

• John Doerr - Alphabet Inc

• Dilip Venkatachari - US Bank

Trouver d'autres anciens étudiants de Rice University

Ils ont aussi étudié à Dartmouth College - The Tuck School of Business:

• Alastair Borthwick - Bank of America
• Michael Cleary - Wells Fargo
• Rob Mailloux - Honeywell

Trouver d'autres anciens étudiants de Dartmouth College - The Tuck School of Business

Voici quelques conseils pour établir rapidement un excellent contact.